carvacrol has been researched along with Mouth Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Bi, L; Chen, H; Liu, H; Wu, R; Xu, X; Yang, Y; Zhang, C | 1 |
Chi, CC; Chou, CT; Jan, CR; Kuo, CC; Liang, WZ; Lin, KL; Lu, T; Pan, CC; Tseng, LL | 1 |
2 other study(ies) available for carvacrol and Mouth Neoplasms
Article | Year |
---|---|
Antioral Squamous Cell Carcinoma Effects of Carvacrol via Inhibiting Inflammation, Proliferation, and Migration Related to Nrf2/Keap1 Pathway.
Topics: Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cymenes; Epithelial-Mesenchymal Transition; Gene Silencing; Humans; Inflammation; Kelch-Like ECH-Associated Protein 1; Lymphatic Metastasis; Mouth Neoplasms; NF-E2-Related Factor 2; NLR Family, Pyrin Domain-Containing 3 Protein; Up-Regulation; Wound Healing | 2021 |
The mechanism of carvacrol-evoked [Ca2+]i rises and non-Ca2+-triggered cell death in OC2 human oral cancer cells.
Topics: Apoptosis; Calcium; Calcium Channels; Carcinoma, Squamous Cell; Caspase 3; Cell Line, Tumor; Cell Survival; Cells, Cultured; Cymenes; Cytosol; Endoplasmic Reticulum; Humans; Male; Monoterpenes; Mouth Neoplasms; Protein Kinase C; Reactive Oxygen Species; Type C Phospholipases | 2013 |